Trump’s 100% Pharma Tariff Hits Indian Stocks

From October 1, 2025, the U.S. will impose a 100% tariff on branded and patented drugs unless firms build plants in America. Nifty Pharma fell 2.3% with

Sun Pharma, Gland, and Natco down up to 4%. Generics remain exempt, supporting Indian exporters, though experts warn tariffs on generics could trigger U.S. drug shortages.